ArticleJournal of cardiovascular echography
Exercise Stress Echo for the Evaluation of the Outcomes of Minimally Invasive Mitral Valve Repair: A 2-year Follow-up Pilot Study.
Article in Journal of cardiovascular echography. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Minimally invasive mitral valve repair (MIMVr) has emerged as a promising alternative to conventional surgery procedures for addressing severe degenerative mitral regurgitation (MR). It provides early benefits such as reduced morbidity, shorter hospital stays, quicker recovery, and consistent long-term safety and efficacy. Exercise stress echocardiography (ESE) is essential for evaluating MR and pulmonary pressures during peak exercise, especially in patients with discordant symptoms and regurgitation grades at rest. ESE helps assess dynamic changes in hemodynamics and guide treatment strategies. Aims: This study evaluates the hemodynamic impacts and clinical outcomes of MIMVr using ESE at 2 years posttreatment. Settings and Design: It is a retrospective study of patients who underwent MIMVr between 2020 and 2021 and ESE-evaluated at 2 years posttreatment. Materials and Methods: In this retrospective cohort study, we compared 13 patients with 13 age-matched healthy controls. All patients underwent resting and stress echocardiography using a semi-supine bicycle ergometer, Bruce, and SIECVI protocols for MR stress-echo. Results: Preoperatively, most subjects were NYHA class II/III, with a shift to class I by 2 years postsurgery. ESE showed significant improvements in ejection fraction (61.4%-73.5%, Conclusions: This pilot study suggests that MIMVr provides meaningful 2-year improvements in cardiac function, approaching normal parameters. However, given the small, single-center design, these findings are primarily hypothesis-generating and warrant confirmation in larger prospective trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.